Are you Dr. Dranoff?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
44 Binney St
Boston, MA 02115Phone+1 617-632-5051Fax+1 617-632-5167
Summary
- Dr. Glenn Dranoff, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Dana-Farber Cancer Institute and is a Professor of Medicine at Dana-Farber Cancer Institute.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1988 - 1991
Massachusetts General HospitalInternship, Internal Medicine, 1985 - 1986
Duke University School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1988 - 2025
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2004
Publications & Presentations
PubMed
- 247 citationsInjectable cryogel-based whole-cell cancer vaccines.Sidi A. Bencherif, R. Warren Sands, Omar Abdel-Rahman Ali, Weiwei Aileen Li, Sarah A. Lewin
Nature Communications. 2015-08-12 - 1101 citationsAdaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.Shohei Koyama, Esra A. Akbay, Yvonne Y. Li, Grit S. Herter-Sprie, Kevin A. Buczkowski
Nature Communications. 2016-02-17 - 406 citationsSequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, Franziska Loebel, Xiuyu Cui
Nature Medicine. 2018-08-13
Press Mentions
Atavistik Bio Announces $60 Million Series a Financing to Advance Genetically-Validated Targets in Metabolic Diseases and CancerAugust 24th, 2021- Wugen Appoints New Vice President and Head of NK Research as the Company Continues to Expand Its PipelineNovember 19th, 2020
Cancer Research Institute Names New Stars of Cancer Immunotherapy ResearchJune 21st, 2019- Join now to see all
